Your browser doesn't support javascript.
loading
Cholestasis secondary to hyperthyroidism in Graves disease: report of one case / Colestasia en un paciente con hipertiroidismo por enfermedad de Graves: informe de un caso
Barra, María I; Olmos, Roberto; Barrera, Francisco; Mosso, Lorena; Domínguez, José M.
Affiliation
  • Barra, María I; Universidad de La Frontera. Facultad de Medicina. Department of Internal Medicine. Temuco. CL
  • Olmos, Roberto; Pontificia Universidad Católica de Chile. Department of Endocrinology and Translational Center of Endocrinology (CETREN). Santiago. CL
  • Barrera, Francisco; Pontificia Universidad Católica de Chile. Facultad de Medicina. Department of Gastroenterology. Santiago. CL
  • Mosso, Lorena; Pontificia Universidad Católica de Chile. Department of Endocrinology and Translational Center of Endocrinology (CETREN). Santiago. CL
  • Domínguez, José M; Pontificia Universidad Católica de Chile. Department of Endocrinology and Translational Center of Endocrinology (CETREN). Santiago. CL
Rev. méd. Chile ; 148(5): 697-701, mayo 2020. tab, graf
Article in En | LILACS | ID: biblio-1139355
Responsible library: CL1.1
ABSTRACT
ABSTRACT Hyperthyroidism can induce elevation in several liver function tests including aminotransferases, alkaline phosphatases and, less frequently, serum bilirubin. These alterations are usually mild and asymptomatic. We report a 26 year-old male presenting with palpitations, progressive jaundice, choluria and generalized itching. Laboratory tests were compatible with hyperthyroidism and a mild elevation of bilirubin, alkaline phosphatases and gamma glutamyl transpeptidase. A liver biopsy showed portal hepatitis with canalicular cholestasis. The patient was treated temporarily with glucocorticoids, cholestyramine and betablockade. Thereafter, he was treated with radioactive iodine, after which serum bilirubin decreased steadily until normalization in ten weeks.
RESUMEN
El hipertiroidismo puede producir elevación de aminotransferasas, fosfatasas alcalinas y, menos frecuentemente, de bilirrubina sérica. Habitualmente, estas alteraciones son leves y asintomáticas. Reportamos un hombre de 26 años con hipertiroidismo secundario a enfermedad de Basedow-Graves, que debutó con un cuadro colestásico, inicialmente estudiado por sospecha de patología hepática autoinmune que incluyó biopsia hepática. Posteriormente, se diagnosticó hipertiroidismo que fue tratado con glucocorticoides, colestiramina y beta bloqueo como puente a terapia definitiva con radioyodo. La evolución mostró disminución progresiva hasta la normalización de bilirrubina sérica.
Subject(s)
Key words

Full text: 1 Index: LILACS Main subject: Graves Disease / Cholestasis / Hyperthyroidism Limits: Adult / Humans / Male Language: En Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2020 Type: Article

Full text: 1 Index: LILACS Main subject: Graves Disease / Cholestasis / Hyperthyroidism Limits: Adult / Humans / Male Language: En Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2020 Type: Article